PCN99 Cost-Effectiveness Evaluation of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in Kazakhstan
No Thumbnail Available
Date
2014-05-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
A. Kostyuk, T. Nurgozhin, T. Mazhitov, A. Almadiyeva, PCN99 - Cost-Effectiveness Evaluation of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in Kazakhstan, In Value in Health, Volume 17, Issue 3, 2014, Page A85